SCHEMBL4493379

SCHEMBL4493379

O=C(CCNCC1CC1)Nc1cccc(NC(=O)CCN2CCC(OC(=O)N(c3ccccc3-c3ccccc3)c3ccccc3-c3ccccc3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 17/20 0.47
ADRB2 P07550 3/20 0.47
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4493377 0.92 CHRM3 (0.43) CHRM3ADRB2NPSR1
SCHEMBL4490821 0.90 CHRM3 (0.43) CHRM3ADRB2NPSR1
SCHEMBL264701 0.88 CHRM3 (0.60) CHRM3
SCHEMBL4482057 0.88 CHRM3 (0.48) CHRM3ADRB2
SCHEMBL4475320 0.88 CHRM3 (0.49) CHRM3ADRB2NPSR1
SCHEMBL4494236 0.87 CHRM3 (0.43) CHRM3ADRB2NPSR1
SCHEMBL4474751 0.85 CHRM3 (0.44) CHRM3ADRB2NPSR1
SCHEMBL4471158 0.83 CHRM3 (0.42) CHRM3
SCHEMBL4478408 0.83 EPHX2 (0.45) CHRM3ADRB2
SCHEMBL4490817 0.83 CHRM3 (0.41) CHRM3ADRB2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632847-B2 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(3-[3-(4-hydroxybenzylamino)propionylamino]benzoylamino)ethyl)piperidin-4-yl ester THERAVANCE, INC. (US) 2009-12-15 US disclosed